Align Technology | ALGN - Current Liabilities


Align Technology reported $1.91B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
3M USD 9.03B 563M Mar/2026
Align Technology USD 1.91B 14.16M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Cardinal Health USD 41.99B 1.33B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cooper Companies USD 1.8B 209M Mar/2026
CVS Health USD 86.41B 2.29B Mar/2026
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Dexcom USD 2.22B 81.3M Mar/2026
Henry Schein USD 3.3B 69M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
McKesson USD 67.02B 1.11B Mar/2026
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Solventum Corp USD 3.35B 210M Mar/2026
Stryker USD 6.32B 1.48B Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veeva Systems USD 1.7B 64.71M Mar/2026
Waters USD 1.24B 11.8M Dec/2025
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026
Zoetis USD 2.05B 182M Mar/2026